nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Cytochrome P450 2D6 Inducers—Phenytoin—epilepsy syndrome	0.462	0.507	CiPCiCtD
Oritavancin—Cytochrome P450 2C19 Inhibitors—Topiramate—epilepsy syndrome	0.162	0.177	CiPCiCtD
Oritavancin—Cytochrome P450 3A4 Inducers—Carbamazepine—epilepsy syndrome	0.156	0.171	CiPCiCtD
Oritavancin—Cytochrome P450 3A4 Inducers—Topiramate—epilepsy syndrome	0.132	0.145	CiPCiCtD
Oritavancin—Skin disorder—Carbamazepine—epilepsy syndrome	0.000129	0.00146	CcSEcCtD
Oritavancin—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000128	0.00145	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Topiramate—epilepsy syndrome	0.000128	0.00145	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000128	0.00145	CcSEcCtD
Oritavancin—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.000128	0.00144	CcSEcCtD
Oritavancin—Infection—Lamotrigine—epilepsy syndrome	0.000128	0.00144	CcSEcCtD
Oritavancin—Urticaria—Fosphenytoin—epilepsy syndrome	0.000127	0.00144	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000127	0.00144	CcSEcCtD
Oritavancin—Nausea—Lacosamide—epilepsy syndrome	0.000127	0.00144	CcSEcCtD
Oritavancin—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000126	0.00143	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000126	0.00143	CcSEcCtD
Oritavancin—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000126	0.00143	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000126	0.00142	CcSEcCtD
Oritavancin—Tachycardia—Lamotrigine—epilepsy syndrome	0.000125	0.00142	CcSEcCtD
Oritavancin—Malnutrition—Valproic Acid—epilepsy syndrome	0.000125	0.00142	CcSEcCtD
Oritavancin—Eosinophilia—Topiramate—epilepsy syndrome	0.000124	0.0014	CcSEcCtD
Oritavancin—Urticaria—Vigabatrin—epilepsy syndrome	0.000124	0.0014	CcSEcCtD
Oritavancin—Hypersensitivity—Midazolam—epilepsy syndrome	0.000124	0.0014	CcSEcCtD
Oritavancin—Nausea—Clobazam—epilepsy syndrome	0.000123	0.00139	CcSEcCtD
Oritavancin—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000123	0.00139	CcSEcCtD
Oritavancin—Dizziness—Acetazolamide—epilepsy syndrome	0.000122	0.00138	CcSEcCtD
Oritavancin—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000122	0.00138	CcSEcCtD
Oritavancin—Urticaria—Diazepam—epilepsy syndrome	0.000122	0.00138	CcSEcCtD
Oritavancin—Pruritus—Propofol—epilepsy syndrome	0.000121	0.00137	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000121	0.00137	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000121	0.00137	CcSEcCtD
Oritavancin—Cardiac disorder—Pregabalin—epilepsy syndrome	0.00012	0.00136	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.00012	0.00136	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.00012	0.00135	CcSEcCtD
Oritavancin—Pruritus—Midazolam—epilepsy syndrome	0.000119	0.00134	CcSEcCtD
Oritavancin—Urticaria—Felbamate—epilepsy syndrome	0.000118	0.00134	CcSEcCtD
Oritavancin—Vomiting—Acetazolamide—epilepsy syndrome	0.000117	0.00133	CcSEcCtD
Oritavancin—Diarrhoea—Propofol—epilepsy syndrome	0.000117	0.00133	CcSEcCtD
Oritavancin—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000117	0.00133	CcSEcCtD
Oritavancin—Immune system disorder—Pregabalin—epilepsy syndrome	0.000117	0.00133	CcSEcCtD
Oritavancin—Pruritus—Levetiracetam—epilepsy syndrome	0.000117	0.00133	CcSEcCtD
Oritavancin—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000117	0.00132	CcSEcCtD
Oritavancin—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000117	0.00132	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000117	0.00132	CcSEcCtD
Oritavancin—Headache—Acetazolamide—epilepsy syndrome	0.000116	0.00131	CcSEcCtD
Oritavancin—Anaemia—Valproic Acid—epilepsy syndrome	0.000116	0.00131	CcSEcCtD
Oritavancin—Urticaria—Zonisamide—epilepsy syndrome	0.000116	0.00131	CcSEcCtD
Oritavancin—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000115	0.0013	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000115	0.0013	CcSEcCtD
Oritavancin—Angioedema—Valproic Acid—epilepsy syndrome	0.000114	0.00129	CcSEcCtD
Oritavancin—Dizziness—Propofol—epilepsy syndrome	0.000113	0.00128	CcSEcCtD
Oritavancin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000113	0.00128	CcSEcCtD
Oritavancin—Pruritus—Fosphenytoin—epilepsy syndrome	0.000113	0.00128	CcSEcCtD
Oritavancin—Hypersensitivity—Diazepam—epilepsy syndrome	0.000113	0.00128	CcSEcCtD
Oritavancin—Malnutrition—Pregabalin—epilepsy syndrome	0.000113	0.00128	CcSEcCtD
Oritavancin—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000113	0.00127	CcSEcCtD
Oritavancin—Infestation NOS—Topiramate—epilepsy syndrome	0.000112	0.00126	CcSEcCtD
Oritavancin—Infestation—Topiramate—epilepsy syndrome	0.000112	0.00126	CcSEcCtD
Oritavancin—Urticaria—Clonazepam—epilepsy syndrome	0.000111	0.00126	CcSEcCtD
Oritavancin—Dizziness—Midazolam—epilepsy syndrome	0.000111	0.00126	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000111	0.00126	CcSEcCtD
Oritavancin—Urticaria—Phenytoin—epilepsy syndrome	0.000111	0.00125	CcSEcCtD
Oritavancin—Cardiac disorder—Gabapentin—epilepsy syndrome	0.00011	0.00125	CcSEcCtD
Oritavancin—Pruritus—Vigabatrin—epilepsy syndrome	0.00011	0.00125	CcSEcCtD
Oritavancin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.00011	0.00125	CcSEcCtD
Oritavancin—Nausea—Acetazolamide—epilepsy syndrome	0.00011	0.00124	CcSEcCtD
Oritavancin—Dizziness—Levetiracetam—epilepsy syndrome	0.00011	0.00124	CcSEcCtD
Oritavancin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000109	0.00124	CcSEcCtD
Oritavancin—Vomiting—Propofol—epilepsy syndrome	0.000109	0.00123	CcSEcCtD
Oritavancin—Pruritus—Diazepam—epilepsy syndrome	0.000109	0.00123	CcSEcCtD
Oritavancin—Rash—Propofol—epilepsy syndrome	0.000108	0.00122	CcSEcCtD
Oritavancin—Dermatitis—Propofol—epilepsy syndrome	0.000108	0.00122	CcSEcCtD
Oritavancin—Immune system disorder—Gabapentin—epilepsy syndrome	0.000108	0.00122	CcSEcCtD
Oritavancin—Headache—Propofol—epilepsy syndrome	0.000107	0.00122	CcSEcCtD
Oritavancin—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000107	0.00121	CcSEcCtD
Oritavancin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000107	0.00121	CcSEcCtD
Oritavancin—Vomiting—Midazolam—epilepsy syndrome	0.000107	0.00121	CcSEcCtD
Oritavancin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000107	0.00121	CcSEcCtD
Oritavancin—Myalgia—Valproic Acid—epilepsy syndrome	0.000106	0.00121	CcSEcCtD
Oritavancin—Rash—Midazolam—epilepsy syndrome	0.000106	0.0012	CcSEcCtD
Oritavancin—Dizziness—Fosphenytoin—epilepsy syndrome	0.000106	0.0012	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000106	0.0012	CcSEcCtD
Oritavancin—Dermatitis—Midazolam—epilepsy syndrome	0.000106	0.0012	CcSEcCtD
Oritavancin—Urticaria—Carbamazepine—epilepsy syndrome	0.000106	0.00119	CcSEcCtD
Oritavancin—Vomiting—Levetiracetam—epilepsy syndrome	0.000105	0.00119	CcSEcCtD
Oritavancin—Headache—Midazolam—epilepsy syndrome	0.000105	0.00119	CcSEcCtD
Oritavancin—Pruritus—Felbamate—epilepsy syndrome	0.000105	0.00119	CcSEcCtD
Oritavancin—Diarrhoea—Diazepam—epilepsy syndrome	0.000105	0.00119	CcSEcCtD
Oritavancin—Rash—Levetiracetam—epilepsy syndrome	0.000104	0.00118	CcSEcCtD
Oritavancin—Anaemia—Pregabalin—epilepsy syndrome	0.000104	0.00118	CcSEcCtD
Oritavancin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000104	0.00118	CcSEcCtD
Oritavancin—Headache—Levetiracetam—epilepsy syndrome	0.000104	0.00118	CcSEcCtD
Oritavancin—Malnutrition—Gabapentin—epilepsy syndrome	0.000104	0.00117	CcSEcCtD
Oritavancin—Angioedema—Pregabalin—epilepsy syndrome	0.000103	0.00117	CcSEcCtD
Oritavancin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000103	0.00117	CcSEcCtD
Oritavancin—Dizziness—Vigabatrin—epilepsy syndrome	0.000103	0.00117	CcSEcCtD
Oritavancin—Pruritus—Zonisamide—epilepsy syndrome	0.000103	0.00116	CcSEcCtD
Oritavancin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000103	0.00116	CcSEcCtD
Oritavancin—Urticaria—Lamotrigine—epilepsy syndrome	0.000102	0.00115	CcSEcCtD
Oritavancin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000102	0.00115	CcSEcCtD
Oritavancin—Nausea—Propofol—epilepsy syndrome	0.000102	0.00115	CcSEcCtD
Oritavancin—Vomiting—Fosphenytoin—epilepsy syndrome	0.000102	0.00115	CcSEcCtD
Oritavancin—Diarrhoea—Felbamate—epilepsy syndrome	0.000102	0.00115	CcSEcCtD
Oritavancin—Dizziness—Diazepam—epilepsy syndrome	0.000101	0.00115	CcSEcCtD
Oritavancin—Infection—Valproic Acid—epilepsy syndrome	0.000101	0.00115	CcSEcCtD
Oritavancin—Rash—Fosphenytoin—epilepsy syndrome	0.000101	0.00114	CcSEcCtD
Oritavancin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000101	0.00114	CcSEcCtD
Oritavancin—Headache—Fosphenytoin—epilepsy syndrome	0.0001	0.00113	CcSEcCtD
Oritavancin—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.0001	0.00113	CcSEcCtD
Oritavancin—Nausea—Midazolam—epilepsy syndrome	9.97e-05	0.00113	CcSEcCtD
Oritavancin—Tachycardia—Valproic Acid—epilepsy syndrome	9.96e-05	0.00113	CcSEcCtD
Oritavancin—Diarrhoea—Zonisamide—epilepsy syndrome	9.95e-05	0.00113	CcSEcCtD
Oritavancin—Pruritus—Clonazepam—epilepsy syndrome	9.91e-05	0.00112	CcSEcCtD
Oritavancin—Vomiting—Vigabatrin—epilepsy syndrome	9.91e-05	0.00112	CcSEcCtD
Oritavancin—Skin disorder—Valproic Acid—epilepsy syndrome	9.91e-05	0.00112	CcSEcCtD
Oritavancin—Oedema peripheral—Topiramate—epilepsy syndrome	9.87e-05	0.00112	CcSEcCtD
Oritavancin—Pruritus—Phenytoin—epilepsy syndrome	9.85e-05	0.00111	CcSEcCtD
Oritavancin—Connective tissue disorder—Topiramate—epilepsy syndrome	9.84e-05	0.00111	CcSEcCtD
Oritavancin—Nausea—Levetiracetam—epilepsy syndrome	9.84e-05	0.00111	CcSEcCtD
Oritavancin—Rash—Vigabatrin—epilepsy syndrome	9.83e-05	0.00111	CcSEcCtD
Oritavancin—Dizziness—Felbamate—epilepsy syndrome	9.82e-05	0.00111	CcSEcCtD
Oritavancin—Dermatitis—Vigabatrin—epilepsy syndrome	9.82e-05	0.00111	CcSEcCtD
Oritavancin—Pruritus—Oxcarbazepine—epilepsy syndrome	9.8e-05	0.00111	CcSEcCtD
Oritavancin—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.79e-05	0.00111	CcSEcCtD
Oritavancin—Headache—Vigabatrin—epilepsy syndrome	9.77e-05	0.00111	CcSEcCtD
Oritavancin—Vomiting—Diazepam—epilepsy syndrome	9.76e-05	0.0011	CcSEcCtD
Oritavancin—Rash—Diazepam—epilepsy syndrome	9.68e-05	0.0011	CcSEcCtD
Oritavancin—Dermatitis—Diazepam—epilepsy syndrome	9.67e-05	0.00109	CcSEcCtD
Oritavancin—Myalgia—Pregabalin—epilepsy syndrome	9.62e-05	0.00109	CcSEcCtD
Oritavancin—Dizziness—Zonisamide—epilepsy syndrome	9.61e-05	0.00109	CcSEcCtD
Oritavancin—Headache—Diazepam—epilepsy syndrome	9.61e-05	0.00109	CcSEcCtD
Oritavancin—Diarrhoea—Clonazepam—epilepsy syndrome	9.59e-05	0.00109	CcSEcCtD
Oritavancin—Anaemia—Gabapentin—epilepsy syndrome	9.58e-05	0.00108	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.56e-05	0.00108	CcSEcCtD
Oritavancin—Diarrhoea—Phenytoin—epilepsy syndrome	9.52e-05	0.00108	CcSEcCtD
Oritavancin—Nausea—Fosphenytoin—epilepsy syndrome	9.5e-05	0.00108	CcSEcCtD
Oritavancin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.47e-05	0.00107	CcSEcCtD
Oritavancin—Erythema multiforme—Topiramate—epilepsy syndrome	9.47e-05	0.00107	CcSEcCtD
Oritavancin—Angioedema—Gabapentin—epilepsy syndrome	9.47e-05	0.00107	CcSEcCtD
Oritavancin—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.46e-05	0.00107	CcSEcCtD
Oritavancin—Vomiting—Felbamate—epilepsy syndrome	9.44e-05	0.00107	CcSEcCtD
Oritavancin—Pruritus—Carbamazepine—epilepsy syndrome	9.4e-05	0.00106	CcSEcCtD
Oritavancin—Rash—Felbamate—epilepsy syndrome	9.37e-05	0.00106	CcSEcCtD
Oritavancin—Dermatitis—Felbamate—epilepsy syndrome	9.36e-05	0.00106	CcSEcCtD
Oritavancin—Headache—Felbamate—epilepsy syndrome	9.31e-05	0.00105	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.3e-05	0.00105	CcSEcCtD
Oritavancin—Cardiac disorder—Topiramate—epilepsy syndrome	9.3e-05	0.00105	CcSEcCtD
Oritavancin—Dizziness—Clonazepam—epilepsy syndrome	9.27e-05	0.00105	CcSEcCtD
Oritavancin—Nausea—Vigabatrin—epilepsy syndrome	9.26e-05	0.00105	CcSEcCtD
Oritavancin—Vomiting—Zonisamide—epilepsy syndrome	9.24e-05	0.00105	CcSEcCtD
Oritavancin—Dizziness—Phenytoin—epilepsy syndrome	9.2e-05	0.00104	CcSEcCtD
Oritavancin—Rash—Zonisamide—epilepsy syndrome	9.17e-05	0.00104	CcSEcCtD
Oritavancin—Infection—Pregabalin—epilepsy syndrome	9.16e-05	0.00104	CcSEcCtD
Oritavancin—Dermatitis—Zonisamide—epilepsy syndrome	9.16e-05	0.00104	CcSEcCtD
Oritavancin—Dizziness—Oxcarbazepine—epilepsy syndrome	9.16e-05	0.00104	CcSEcCtD
Oritavancin—Nausea—Diazepam—epilepsy syndrome	9.12e-05	0.00103	CcSEcCtD
Oritavancin—Headache—Zonisamide—epilepsy syndrome	9.11e-05	0.00103	CcSEcCtD
Oritavancin—Diarrhoea—Carbamazepine—epilepsy syndrome	9.09e-05	0.00103	CcSEcCtD
Oritavancin—Pruritus—Lamotrigine—epilepsy syndrome	9.08e-05	0.00103	CcSEcCtD
Oritavancin—Immune system disorder—Topiramate—epilepsy syndrome	9.05e-05	0.00102	CcSEcCtD
Oritavancin—Nervous system disorder—Pregabalin—epilepsy syndrome	9.05e-05	0.00102	CcSEcCtD
Oritavancin—Mediastinal disorder—Topiramate—epilepsy syndrome	9.03e-05	0.00102	CcSEcCtD
Oritavancin—Tachycardia—Pregabalin—epilepsy syndrome	9e-05	0.00102	CcSEcCtD
Oritavancin—Skin disorder—Pregabalin—epilepsy syndrome	8.96e-05	0.00101	CcSEcCtD
Oritavancin—Vomiting—Clonazepam—epilepsy syndrome	8.91e-05	0.00101	CcSEcCtD
Oritavancin—Vomiting—Phenytoin—epilepsy syndrome	8.85e-05	0.001	CcSEcCtD
Oritavancin—Rash—Clonazepam—epilepsy syndrome	8.83e-05	0.001	CcSEcCtD
Oritavancin—Dermatitis—Clonazepam—epilepsy syndrome	8.83e-05	0.000999	CcSEcCtD
Oritavancin—Myalgia—Gabapentin—epilepsy syndrome	8.82e-05	0.000999	CcSEcCtD
Oritavancin—Nausea—Felbamate—epilepsy syndrome	8.82e-05	0.000999	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.81e-05	0.000997	CcSEcCtD
Oritavancin—Vomiting—Oxcarbazepine—epilepsy syndrome	8.8e-05	0.000997	CcSEcCtD
Oritavancin—Dizziness—Carbamazepine—epilepsy syndrome	8.79e-05	0.000995	CcSEcCtD
Oritavancin—Diarrhoea—Lamotrigine—epilepsy syndrome	8.79e-05	0.000995	CcSEcCtD
Oritavancin—Headache—Clonazepam—epilepsy syndrome	8.78e-05	0.000994	CcSEcCtD
Oritavancin—Rash—Phenytoin—epilepsy syndrome	8.78e-05	0.000994	CcSEcCtD
Oritavancin—Dermatitis—Phenytoin—epilepsy syndrome	8.77e-05	0.000993	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.76e-05	0.000992	CcSEcCtD
Oritavancin—Rash—Oxcarbazepine—epilepsy syndrome	8.73e-05	0.000988	CcSEcCtD
Oritavancin—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.72e-05	0.000987	CcSEcCtD
Oritavancin—Headache—Phenytoin—epilepsy syndrome	8.72e-05	0.000987	CcSEcCtD
Oritavancin—Malnutrition—Topiramate—epilepsy syndrome	8.72e-05	0.000987	CcSEcCtD
Oritavancin—Headache—Oxcarbazepine—epilepsy syndrome	8.67e-05	0.000982	CcSEcCtD
Oritavancin—Nausea—Zonisamide—epilepsy syndrome	8.64e-05	0.000978	CcSEcCtD
Oritavancin—Dizziness—Lamotrigine—epilepsy syndrome	8.49e-05	0.000961	CcSEcCtD
Oritavancin—Vomiting—Carbamazepine—epilepsy syndrome	8.45e-05	0.000956	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.4e-05	0.000951	CcSEcCtD
Oritavancin—Infection—Gabapentin—epilepsy syndrome	8.4e-05	0.000951	CcSEcCtD
Oritavancin—Rash—Carbamazepine—epilepsy syndrome	8.38e-05	0.000948	CcSEcCtD
Oritavancin—Dermatitis—Carbamazepine—epilepsy syndrome	8.37e-05	0.000948	CcSEcCtD
Oritavancin—Nausea—Clonazepam—epilepsy syndrome	8.32e-05	0.000942	CcSEcCtD
Oritavancin—Headache—Carbamazepine—epilepsy syndrome	8.32e-05	0.000942	CcSEcCtD
Oritavancin—Nervous system disorder—Gabapentin—epilepsy syndrome	8.3e-05	0.000939	CcSEcCtD
Oritavancin—Nausea—Phenytoin—epilepsy syndrome	8.27e-05	0.000936	CcSEcCtD
Oritavancin—Tachycardia—Gabapentin—epilepsy syndrome	8.26e-05	0.000935	CcSEcCtD
Oritavancin—Nausea—Oxcarbazepine—epilepsy syndrome	8.22e-05	0.000931	CcSEcCtD
Oritavancin—Skin disorder—Gabapentin—epilepsy syndrome	8.22e-05	0.00093	CcSEcCtD
Oritavancin—Vomiting—Lamotrigine—epilepsy syndrome	8.16e-05	0.000924	CcSEcCtD
Oritavancin—Urticaria—Valproic Acid—epilepsy syndrome	8.11e-05	0.000918	CcSEcCtD
Oritavancin—Rash—Lamotrigine—epilepsy syndrome	8.1e-05	0.000917	CcSEcCtD
Oritavancin—Dermatitis—Lamotrigine—epilepsy syndrome	8.09e-05	0.000916	CcSEcCtD
Oritavancin—Anaemia—Topiramate—epilepsy syndrome	8.06e-05	0.000912	CcSEcCtD
Oritavancin—Headache—Lamotrigine—epilepsy syndrome	8.04e-05	0.000911	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.96e-05	0.000902	CcSEcCtD
Oritavancin—Nausea—Carbamazepine—epilepsy syndrome	7.89e-05	0.000893	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.71e-05	0.000872	CcSEcCtD
Oritavancin—Nausea—Lamotrigine—epilepsy syndrome	7.63e-05	0.000864	CcSEcCtD
Oritavancin—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.52e-05	0.000851	CcSEcCtD
Oritavancin—Myalgia—Topiramate—epilepsy syndrome	7.42e-05	0.00084	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.37e-05	0.000835	CcSEcCtD
Oritavancin—Urticaria—Pregabalin—epilepsy syndrome	7.33e-05	0.00083	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.3e-05	0.000827	CcSEcCtD
Oritavancin—Pruritus—Valproic Acid—epilepsy syndrome	7.22e-05	0.000817	CcSEcCtD
Oritavancin—Infection—Topiramate—epilepsy syndrome	7.07e-05	0.0008	CcSEcCtD
Oritavancin—Diarrhoea—Valproic Acid—epilepsy syndrome	6.98e-05	0.00079	CcSEcCtD
Oritavancin—Nervous system disorder—Topiramate—epilepsy syndrome	6.98e-05	0.00079	CcSEcCtD
Oritavancin—Tachycardia—Topiramate—epilepsy syndrome	6.95e-05	0.000786	CcSEcCtD
Oritavancin—Skin disorder—Topiramate—epilepsy syndrome	6.91e-05	0.000783	CcSEcCtD
Oritavancin—Hypersensitivity—Pregabalin—epilepsy syndrome	6.8e-05	0.000769	CcSEcCtD
Oritavancin—Dizziness—Valproic Acid—epilepsy syndrome	6.75e-05	0.000764	CcSEcCtD
Oritavancin—Urticaria—Gabapentin—epilepsy syndrome	6.72e-05	0.000761	CcSEcCtD
Oritavancin—Pruritus—Pregabalin—epilepsy syndrome	6.53e-05	0.000739	CcSEcCtD
Oritavancin—Vomiting—Valproic Acid—epilepsy syndrome	6.49e-05	0.000734	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.48e-05	0.000734	CcSEcCtD
Oritavancin—Rash—Valproic Acid—epilepsy syndrome	6.43e-05	0.000728	CcSEcCtD
Oritavancin—Dermatitis—Valproic Acid—epilepsy syndrome	6.43e-05	0.000728	CcSEcCtD
Oritavancin—Headache—Valproic Acid—epilepsy syndrome	6.39e-05	0.000724	CcSEcCtD
Oritavancin—Diarrhoea—Pregabalin—epilepsy syndrome	6.31e-05	0.000715	CcSEcCtD
Oritavancin—Hypersensitivity—Gabapentin—epilepsy syndrome	6.23e-05	0.000706	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.14e-05	0.000696	CcSEcCtD
Oritavancin—Dizziness—Pregabalin—epilepsy syndrome	6.1e-05	0.000691	CcSEcCtD
Oritavancin—Nausea—Valproic Acid—epilepsy syndrome	6.06e-05	0.000686	CcSEcCtD
Oritavancin—Pruritus—Gabapentin—epilepsy syndrome	5.98e-05	0.000678	CcSEcCtD
Oritavancin—Vomiting—Pregabalin—epilepsy syndrome	5.86e-05	0.000664	CcSEcCtD
Oritavancin—Rash—Pregabalin—epilepsy syndrome	5.82e-05	0.000658	CcSEcCtD
Oritavancin—Dermatitis—Pregabalin—epilepsy syndrome	5.81e-05	0.000658	CcSEcCtD
Oritavancin—Diarrhoea—Gabapentin—epilepsy syndrome	5.79e-05	0.000655	CcSEcCtD
Oritavancin—Headache—Pregabalin—epilepsy syndrome	5.78e-05	0.000654	CcSEcCtD
Oritavancin—Urticaria—Topiramate—epilepsy syndrome	5.65e-05	0.00064	CcSEcCtD
Oritavancin—Dizziness—Gabapentin—epilepsy syndrome	5.59e-05	0.000633	CcSEcCtD
Oritavancin—Nausea—Pregabalin—epilepsy syndrome	5.48e-05	0.00062	CcSEcCtD
Oritavancin—Vomiting—Gabapentin—epilepsy syndrome	5.38e-05	0.000609	CcSEcCtD
Oritavancin—Rash—Gabapentin—epilepsy syndrome	5.33e-05	0.000604	CcSEcCtD
Oritavancin—Dermatitis—Gabapentin—epilepsy syndrome	5.33e-05	0.000603	CcSEcCtD
Oritavancin—Headache—Gabapentin—epilepsy syndrome	5.3e-05	0.0006	CcSEcCtD
Oritavancin—Hypersensitivity—Topiramate—epilepsy syndrome	5.24e-05	0.000594	CcSEcCtD
Oritavancin—Pruritus—Topiramate—epilepsy syndrome	5.03e-05	0.00057	CcSEcCtD
Oritavancin—Nausea—Gabapentin—epilepsy syndrome	5.02e-05	0.000569	CcSEcCtD
Oritavancin—Diarrhoea—Topiramate—epilepsy syndrome	4.87e-05	0.000551	CcSEcCtD
Oritavancin—Dizziness—Topiramate—epilepsy syndrome	4.71e-05	0.000533	CcSEcCtD
Oritavancin—Vomiting—Topiramate—epilepsy syndrome	4.52e-05	0.000512	CcSEcCtD
Oritavancin—Rash—Topiramate—epilepsy syndrome	4.49e-05	0.000508	CcSEcCtD
Oritavancin—Dermatitis—Topiramate—epilepsy syndrome	4.48e-05	0.000508	CcSEcCtD
Oritavancin—Headache—Topiramate—epilepsy syndrome	4.46e-05	0.000505	CcSEcCtD
Oritavancin—Nausea—Topiramate—epilepsy syndrome	4.23e-05	0.000479	CcSEcCtD
